NCT00372515 2018-01-31
High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations
Dana-Farber Cancer Institute
Phase 1 Completed
Dana-Farber Cancer Institute
Wake Forest University Health Sciences
Lady Davis Institute
Memorial Sloan Kettering Cancer Center